Browsing: biotech investing
At Amgen, Dr. Jay Bradner, the Executive Vice President of Research and Development and Chief Scientific Officer, emphasized the strategic…
Amgen (NASDAQ:AMGN) recently shared new data on IMDELLTRA TM (tarlatamab-dlle), a novel delta-like ligand 3 (DLL3)-targeting Bispecific T-cell Engager (BiTE…
Amgen, a leading biotechnology company (NASDAQ: AMGN), has announced the presentation of new data on IMDELLTRA TM, a first-in-class delta-like…
Amgen announced the presentation of new data on IMDELLTRA TM (tarlatamab-dlle), a first-in-class delta-like ligand 3 (DLL3)-targeting Bispecific T-cell Engager…
During the pandemic, there was a noticeable disparity in healthcare outcomes, particularly for patients of color in comparison to their…
Amgen has announced the approval of a new oral treatment option for children and adolescents with moderate to severe plaque…
Radiopharm Ventures has announced that RAD has increased its ownership stake in the company to 75%. This move demonstrates RAD’s…
CLEO, a renowned healthcare organization, has chosen several clinical trial sites located in the United States. These selected sites will…
The proceeds from the Third Tranche will be used for the development of the Company’s Murdock Property and for general…
Key results include: For the second quarter, total revenues increased 20% to $8.4 billion in comparison to the second quarter…